São Paulo, Brazil

Katia Conceição


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katia Conceição: Innovator in Anti-Inflammatory Peptides

Introduction

Katia Conceição is a prominent inventor based in São Paulo, Brazil. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and anti-allergic cyclic peptides. Her innovative work has the potential to impact the treatment of various allergic conditions, including asthma.

Latest Patents

Katia holds a patent for her invention titled "Anti-inflammatory and anti-allergic cyclic peptides." This invention refers to synthetic, cyclic peptides containing a sequence of 13 L-amino acids in their primary structure. These peptides exhibit anti-inflammatory and anti-allergic activities, making them useful for treating acute or chronic inflammation and allergies. The invention also includes a pharmaceutical composition containing these peptides, along with methods for treating or preventing inflammatory and allergic disorders.

Career Highlights

Throughout her career, Katia has worked with notable companies such as Cristalia Produtos Químicos Farmacêuticos Ltda. and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Katia has collaborated with talented professionals in her field, including Mônica Ferreira and Carla Silva. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Katia Conceição's work in developing anti-inflammatory and anti-allergic cyclic peptides showcases her dedication to advancing medical science. Her contributions have the potential to improve the quality of life for individuals suffering from allergic conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…